Patented Biomaterial Used in Catheter Designed to Reduce Thrombus Accumulation 1 HydroMID is a 4 French, single lumen, midline catheter with a maximum usable length of 20cm. HydroMID will be made ...
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter Access Vascular, Inc. (AVI), a leader in ...
BILLERICA, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today shared initial findings from a retrospective review of patient records that demonstrates an increase in dwell ...
BILLERICA, Mass., September 15, 2026--(BUSINESS WIRE)--Access Vascular, Inc. (AVI), a medical device company specializing in developing advanced vascular access solutions, today announced its ...
The last decade of evolution in the efforts to reduce healthcare-acquired infections (HAIs) has seen a multitude of new initiatives and requirements that address, among other issues, the elimination ...
(MENAFN- EIN Presswire) Osprey commercialization launches with early clinical success and new patent protection. The ability to access with an integrated midline system over a more expensive and ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Access Vascular, Inc. (AVI), a leader in advanced ...
CARLSBAD, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal ...
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter Access Vascular, Inc. (AVI), a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results